Trade Summary

3 days ago, Vairavan Latha, serving as SVP CFO at Arcutis Biotherapeutics, Inc. (ARQT), sold 2,853 shares at $25.18 per share, for a total transaction value of $71,844.00. Following this transaction, Vairavan Latha now holds 87,754 shares of ARQT.

This sale represents a 3.00% decrease in Vairavan Latha's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.